The MRFID project develops diagnostic technologies that allow the promotion of personalized medicine for the prostate cancer treatment.
Advanced diagnostic imaging systems are developed by using markers embedded in smart and reabsorbable polymeric nanomaterials that improve tumor detection, increasing the efficiency of the current therapies. The project facilitates the personalization of the treatment and the reduction of adverse effects derived from the healthy tissue irradiation.
AIMPLAS | ERESA
Do you want more information about MRFID project?
Complete the following fields.
Would you like to talk?
Director of Projects